X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Lupus Foundation of America Event Calls for More Progress for Patients

By Michelle Nyman  |    June 30, 2015
Optimism and hope. That’s what NBC’s Chuck Todd took away from the Lupus Foundation of America’s National Advocacy Awards Dinner on June 16. Todd moderated a thoughtful discussion among health...   Read More

New Report: Innovation in the Biopharmaceutical R&D Process – Adapting to a Changing Environment

By Anne McDonald Pritchett, PhD  |    June 30, 2015
With the average cost of developing, testing and receiving approval for a new medicine at $2.6 billion and rising, biopharmaceutical companies are continuously looking at new ways to increase...   Read More

Medicare Monday: What is CMMI?

By Kelsey Lang  |    June 29, 2015
This week Medicare Monday is looking at the Center for Medicare and Medicaid Innovation (CMMI) and why it matters to patients. The Center for Medicare and Medicaid Innovation (CMMI) is a...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    June 26, 2015
Fighting High Cholesterol: The prevalence of high cholesterol among American adults underscores the importance of continued innovation. Take a look at the new infographic on fighting high...   Read More

ICYMI: The Importance of Enrolling in Clinical Trials

By Emma Van Hook  |    June 26, 2015
Clinical trials are a crucial step in the long and costly process of researching and developing a new medicine to address substantial unmet medical needs in such areas as Alzheimer’s, cancer, and...   Read More

Fighting High Cholesterol

By Holly Campbell  |    June 25, 2015
High cholesterol itself is not a disease, but it can lead to disease. After all, every 40 seconds, an American adult dies from a heart attack, stroke, or related vascular disease. Despite being...   Read More

Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans

By Allyson Funk  |    June 24, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to...   Read More

ASCO’s Framework: Value at the Crossroads

By Randy Burkholder  |    June 23, 2015
Yesterday the American Society of Clinical Oncology (ASCO) released its long-awaited draft conceptual framework to assess the value of cancer treatment options. PhRMA has long supported the...   Read More

Medicare Monday: Managing Chronic Conditions

By Allyson Funk  |    June 22, 2015
According to the Centers for Disease Control and Prevention, two in three older Americans live with multiple chronic conditions. Chronic conditions may include Alzheimer’s and dementia, arthritis,...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    June 19, 2015
Burden on Patients: Access to medicines is important for patients who are managing chronic conditions. In the latest edition of the ”Burden on Patients” series, we’re taking a look at the barriers...   Read More

Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans

By Allyson Funk  |    June 18, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to mental...   Read More

Ask About Adherence: Q&A with PhRMA Foundation Young Investigator Adherence Grantee - Xian Shen

By Samantha Dougherty  |    June 18, 2015
Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Xian Shen, a 2015 PhRMA Foundation Young Investigator Adherence grantee about...   Read More

Burden on Patients: Access to Medicines in Exchange Plans

By Allyson Funk  |    June 17, 2015
Access to prescription medicines is a critical component of health care coverage, particularly for patients living with and managing chronic conditions. In the coming weeks, we’ll be highlighting...   Read More

3 Reasons Innovation Depends On Strong IP Protections in the TPP

By Tina Stow  |    June 16, 2015
As Congress continues to debate Trade Promotion Authority (TPA), it is important to keep in mind why the Trans-Pacific Partnership (TPP) – the largest trade deal in history – can and should help...   Read More

Medicare Monday: Why the Independent Payment Advisory Board is Bad For Patients

By Allyson Funk  |    June 15, 2015
The Independent Payment Advisory Board (IPAB) – created by the Affordable Care Act – could come between patients and their health care providers. If Medicare growth exceeds a certain target, IPAB...   Read More

New Study: Policy Environment Has a Significant Impact on Biopharmaceutical Investment

By Guest Contributor  |    June 11, 2015
Economies’ policy trajectories have a significant impact on biopharmaceutical investment decisions, perhaps more than costs and market size, according to local executives. A new study from Pugatch...   Read More

New Data on Health Insurance Exchange Plans Shows Cost Sharing Increasing for Some Medicines

By Karyn Schwartz  |    June 11, 2015
One primary reason people buy health insurance is to protect themselves from unpredictable and unaffordable health care costs. But when patients face high coinsurance—meaning they have to pay a...   Read More

Who Benefits from the 340B Drug Discount Program?

By Allyson Funk  |    June 10, 2015
The 340B program was created by Congress in 1992 to help vulnerable or uninsured patients gain access to needed prescription medicines, by requiring pharmaceutical manufacturers to provide steep...   Read More

Medicare Monday: New Research on How Successfully Managing Diabetes Helps Patients and Part D Save

By Allyson Funk  |    June 8, 2015
An important aspect of Medicare Part D is access to affordable prescription drug coverage so that beneficiaries can get the medicines they need, take them as directed and avoid costly...   Read More

Avalere Insights on Latest Evidence Communication Research

By Guest Contributor  |    June 6, 2015
Jay Jackson, Nikita Jeswani and Corinna Sorenson are all consultants for Avalere Health and provide strategic counsel to life sciences clients on a variety of policy-related issues. Jackson...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    June 5, 2015
Who is Making Decisions About Your Health? This week, the Catalyst featured key information about fail first and prior authorization processes, which are methods used by health insurers to limit...   Read More

New Chart Pack: Advancing Innovative Treatment Options for Patients Through Personalized Medicine

By Emma Van Hook  |    June 4, 2015
We’re at a remarkable time in medicine, where the rapid pace of science is enabling researchers to make tremendous advances against some of the most devastating diseases. One of the most promising...   Read More

Who is Making Decisions About Your Health Care?

By Allyson Funk  |    June 4, 2015
AccessBetterCoverage.org is a great resource for understanding health coverage and the right questions to ask when shopping for coverage. Our Insurance Basics address important topics like 5...   Read More

340B Spotlight: A Look at 340B Purchases

By Karyn Schwartz  |    June 3, 2015
If you are familiar with the 340B program, you have probably heard the oft-cited assertion that 340B only represents 2% of pharmaceutical sales.[1] But just because a statistic is widely repeated,...   Read More

Newly Implemented Expanded Access Principles Support Commitment to Patients

By Bill Chin, M.D.  |    June 3, 2015
Biopharmaceutical companies are committed to helping patients gain access to the best possible care, and its researchers are constantly looking for ways to provide more therapeutic options for...   Read More

New Video: How Medicines Can Curb Health Care Costs

By Holly Campbell  |    June 2, 2015
Hospital visits, surgeries and long-term care place a heavy burden on our nation’s health care system, and the weight is only projected to increase. In just the next decade, the U.S. will spend...   Read More

Upcoming Forum on Improving Critical Tools for Preventing Prescription Drug Abuse

By Anne McDonald Pritchett, PhD  |    June 1, 2015
On June 2, the Network for Excellence in Health Innovation (NEHI) will bring experts from across the country to Boston to discuss a critical public health challenge—the abuse of prescription...   Read More

New Research Highlights Gaps in Quality Measures for Cancer Patients

By Randy Burkholder  |    June 1, 2015
This weekend marked the start of the annual meeting of The American Society of Clinical Oncology (ASCO).  This year’s meeting, which features a theme of “Innovation and Illumination,” highlights...   Read More

Medicare Monday: Protecting Beneficiaries Who Receive Extra Help

By Allyson Funk  |    June 1, 2015
Welcome back to #MedicareMonday where this week we’re talking about Medicare Part D’s Extra Help program. The Extra Help Program—also known as Low-Income Subsidies (LIS)—is designed to help...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates